Show simple item record

Nove forme imunoterapije alergijskih oboljenja

dc.creatorĆirković-Veličković, Tanja
dc.date.accessioned2018-11-22T00:12:15Z
dc.date.available2018-11-22T00:12:15Z
dc.date.issued2008
dc.identifier.issn0440-6826
dc.identifier.urihttp://cherry.chem.bg.ac.rs/handle/123456789/261
dc.description.abstractThe prevalence of allergic disorders, such as hay fever and asthma has increased worldwide, mostly in westernized countries where up to 20 % of the population are affected. In recent years, a better understanding of the immunopathogenesis of allergic diseases has evolved, which has contributed to the development of novel more targeted forms of therapy. Allergen injection immunotherapy is the only treatment in current use with the curative potential. The use of modified allergens, allergen peptides and the use of novel adjuvant represent alternatives to conventional immunotherapy with potential for improved efficacy with less side effects. Although, immunomodulatory strategies provide a promising outlook for the treatment of allergic patients, more studies are needed in the future to address issues of efficacy, safety and long-term effects of altered immune responses.en
dc.rightsopenAccess
dc.sourceHemijski pregled
dc.titleNew forms of immunotherapies of allergic diseasesen
dc.titleNove forme imunoterapije alergijskih oboljenjasr
dc.typearticle
dc.rights.licenseARR
dcterms.abstractЋирковић-Величковић, Тања; Нове форме имунотерапије алергијских обољења; Нове форме имунотерапије алергијских обољења;
dc.citation.volume49
dc.citation.issue1
dc.citation.spage7
dc.citation.epage14
dc.citation.other49(1): 7-14
dc.type.versionpublishedVersion
dc.identifier.fulltexthttp://cherry.chem.bg.ac.rs/bitstream/id/9528/259.pdf
dc.identifier.rcubKon_533


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record